Is there an increased cancer risk associated with the use of angiotensin receptor blockers and should it affect current prescribing?
作者信息
Cohen Debbie L, Townsend Raymond R
机构信息
Department of Medicine, Hypertension Program, University of Pennsylvania, School of Medicine, Philadelphia, PA 19104, USA.
出版信息
J Clin Hypertens (Greenwich). 2011 Feb;13(2):131-2. doi: 10.1111/j.1751-7176.2010.00403.x. Epub 2010 Dec 17.
Abstract
摘要
相似文献
1
Is there an increased cancer risk associated with the use of angiotensin receptor blockers and should it affect current prescribing?使用血管紧张素受体阻滞剂是否会增加患癌风险，这是否会影响当前的处方用药？
J Clin Hypertens (Greenwich). 2011 Feb;13(2):131-2. doi: 10.1111/j.1751-7176.2010.00403.x. Epub 2010 Dec 17.
2
Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study.老年患者潜在不适当的抗高血压药物处方：一项前瞻性观察性研究的结果
Drugs Aging. 2017 Jun;34(6):453-466. doi: 10.1007/s40266-017-0452-z.
3
Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers.血管紧张素转换酶抑制剂与血管紧张素受体阻滞剂的比较
Am Fam Physician. 2015 Feb 1;91(3):193-4.
4
Angiotensin receptor blockers for the treatment of hypertension in children.
Clin Pediatr (Phila). 2011 Sep;50(9):791-6. doi: 10.1177/0009922810388514. Epub 2010 Dec 2.
5
Could NICE guidance on the choice of blood pressure lowering drugs be simplified?英国国家卫生与临床优化研究所（NICE）关于降压药物选择的指南能否简化？
BMJ. 2012 Jan 13;344:d8078. doi: 10.1136/bmj.d8078.
6
Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States.美国门诊医生抗高血压药物处方的长期和短期变化。
Hypertension. 2006 Aug;48(2):213-8. doi: 10.1161/01.HYP.0000229653.73128.b6. Epub 2006 Jun 19.
7
[Practice of antihypertensive treatment in diabetic patients with hypertension in Hungary].[匈牙利糖尿病合并高血压患者的降压治疗实践]
Orv Hetil. 2014 Oct 26;155(43):1695-700. doi: 10.1556/OH.2014.29988.
8
Why are we still using hydrochlorothiazide?我们为什么还在使用氢氯噻嗪？
J Clin Hypertens (Greenwich). 2011 Dec;13(12):867-9. doi: 10.1111/j.1751-7176.2011.00566.x. Epub 2011 Dec 1.
9
Antihypertensive Prescribing Pattern in Older Adults: Implications of Age and the Use of Dual Single-Pill Combinations.老年人的降压处方模式：年龄及使用双重单 Pill 组合的影响
High Blood Press Cardiovasc Prev. 2019 Dec;26(6):535-544. doi: 10.1007/s40292-019-00353-1. Epub 2019 Dec 3.
10
Physician prescribing patterns of antihypertensives in diabetic patients before and after the implementation of Taiwan's guideline for the management of hypertension.
J Formos Med Assoc. 2018 Jul;117(7):650-651. doi: 10.1016/j.jfma.2018.05.010. Epub 2018 May 24.
引用本文的文献
1
Angiotensin and systems thinking: wrapping your mind around the big picture.血管紧张素与系统思维：从整体角度理解全局
Ochsner J. 2013 Spring;13(1):11-25.
本文引用的文献
1
Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials.血管紧张素受体阻断剂与癌症风险：随机对照试验的荟萃分析。
Lancet Oncol. 2010 Jul;11(7):627-36. doi: 10.1016/S1470-2045(10)70106-6. Epub 2010 Jun 11.
2
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.在有效避免二次中风预防方案（PRoFESS）试验中，阿司匹林加缓释双嘧达莫与氯吡格雷及替米沙坦对缺血性中风患者复发性中风后残疾和认知功能的影响：一项双盲、活性药物与安慰剂对照研究。
Lancet Neurol. 2008 Oct;7(10):875-84. doi: 10.1016/S1474-4422(08)70198-4. Epub 2008 Aug 29.
3
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.血管紧张素受体阻滞剂替米沙坦对不耐受血管紧张素转换酶抑制剂的高危患者心血管事件的影响：一项随机对照试验。
Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29.
4
Telmisartan, ramipril, or both in patients at high risk for vascular events.替米沙坦、雷米普利或两者联合用于血管事件高危患者。
N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31.
5
Angiotensin receptors: a new role in cancer?血管紧张素受体：在癌症中扮演新角色？
Trends Endocrinol Metab. 2005 Sep;16(7):293-9. doi: 10.1016/j.tem.2005.07.009.
6
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.坎地沙坦对慢性心力衰竭患者死亡率和发病率的影响：CHARM总体研究项目
Lancet. 2003 Sep 6;362(9386):759-66. doi: 10.1016/s0140-6736(03)14282-1.
7
Carcinogenicity of antihypertensive therapy.抗高血压治疗的致癌性。
Curr Hypertens Rep. 2002 Jun;4(3):195-201. doi: 10.1007/s11906-002-0007-4.
8
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.氯沙坦干预降低高血压终点事件研究（LIFE）中的心血管发病率和死亡率：一项与阿替洛尔对比的随机试验。
Lancet. 2002 Mar 23;359(9311):995-1003. doi: 10.1016/S0140-6736(02)08089-3.
9
Does diuretic therapy increase the risk of renal cell carcinoma?
Am J Cardiol. 1999 Apr 1;83(7):1090-3. doi: 10.1016/s0002-9149(99)00021-1.
10
Is the use of some calcium antagonists linked to cancer? Evidence from recent observational studies.某些钙拮抗剂的使用与癌症有关吗？来自近期观察性研究的证据。
Drugs Aging. 1998 Aug;13(2):99-108. doi: 10.2165/00002512-199813020-00002.
Zotero 插件